Eladocagene exuparvovec

Upstaza 2,8 × 10E11 Genomas Vectoriales (VG)/0,5 ML Para Solucion Para Perfusion

5,6 10e11 vg/ml solución para perfusiónSpainAuthorisedAuthorised 22 Dec 2022

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

UpstazaEuropean UnionAuthorised

UpstazaBrazil · PTC Farmaceutica do Brasil Ltda.Same brand
UpstazaEuropean Union · PTC Therapeutics International LimitedSame brand
UpstazaCroatiaSame brand
UpstazaItaly · Soluzione per infusione · PTC Therapeutics International LimitedSame brand
Upstaza 2,8 x 10^11 vg/0.5 ml, oplossing voor infusieNetherlands · Oplossing voor infusie · PTC Therapeutics International LimitedSame brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Eladocagene exuparvovec

Upstaza 2,8 × 10E11 Genomas Vectoriales (VG)/0,5 ML Para Solucion Para Perfusion

5,6 10e11 vg/ml solución para perfusiónSpainAuthorisedAuthorised 22 Dec 2022

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

UpstazaEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Upstaza 2.8 × 10^11 vector genomes (vg)/0.5 mL solution for infusion

Taiwan · 注射液劑 · 吉帝藥品股份有限公司

KebilidiUnited States · 5.6x10^11VG/ML · Suspension · PTC Therapeutics

Packs

Pack	Code	Status
UPSTAZA 2,8 × 10E11 GENOMAS VECTORIALES (VG)/0,5 ML PARA SOLUCION PARA PERFUSION, 1 vial de 0,5 ml	759317

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Eladocagene exuparvovec
Strength: 5,6 10e11 vg/ml
Dosage form: solución para perfusión
Route: uso intraputaminal
Register: Spain (AEMPS)
Status: Authorised
Status in the register: Autorizado, no comercializado
Authorised: 22 Dec 2022
Registration: 1221653001
Marketing authorisation holder: Ptc Therapeutics International Limited
Procedure: EU centralised
Supply: Uso Hospitalario
EU number: EU/1/22/1653